Moreover, it has been reported that miR-134/487b/665 cluster governed transforming growth factor-β (TGF-β)-mediated EMT and drug resistance to gefitinib by targeting membrance associated guanylate kinase inverted 2 (MAGI2) in lung cancer cells [39]. The gene discussed is MAGI2; the disease is lung carcinoma.